Shuhui Li
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells" [Canc. Lett. 584 (2024) 216598].
Journal: Cancer letters
Published: March 05, 2025
Targeting S100A9 Prevents β-Adrenergic Activation-Induced Cardiac Injury.
Journal: Inflammation
Published: December 05, 2023
CircPHKB decreases the sensitivity of liver cancer cells to sorafenib via miR-1234-3p/CYP2W1 axis.
Journal: Genomics
Published: June 26, 2023
Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells.
Journal: Biochemical pharmacology
Published: December 07, 2022
Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Journal: Experimental cell research
Published: January 29, 2021
Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice.
Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice.
Journal: Journal of neuroinflammation
Published: January 15, 2021
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Journal: Frontiers in molecular biosciences
Published: September 29, 2020
Landscape of active enhancers developed de novo in cirrhosis and conserved in hepatocellular carcinoma.
Journal: American journal of cancer research
Published: August 05, 2020
The double-edged sword effect of macrophage targeting delivery system in different macrophage subsets related diseases.
Journal: Journal of nanobiotechnology
Published: July 11, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026